Follow
Catherine Blish
Catherine Blish
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Integrated analysis of multimodal single-cell data
Y Hao, S Hao, E Andersen-Nissen, WM Mauck, S Zheng, A Butler, MJ Lee, ...
Cell 184 (13), 3573-3587. e29, 2021
60282021
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
AJ Wilk, A Rustagi, NQ Zhao, J Roque, GJ Martínez-Colón, JL McKechnie, ...
Nature medicine 26 (7), 1070-1076, 2020
13762020
Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells
EJ Grow, RA Flynn, SL Chavez, NL Bayless, M Wossidlo, DJ Wesche, ...
Nature 522 (7555), 221-225, 2015
6102015
Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry
A Horowitz, DM Strauss-Albee, M Leipold, J Kubo, N Nemat-Gorgani, ...
Science translational medicine 5 (208), 208ra145-208ra145, 2013
5842013
The immunology and immunopathology of COVID-19
M Merad, CA Blish, F Sallusto, A Iwasaki
Science 375 (6585), 1122-1127, 2022
5182022
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
K Röltgen, AE Powell, OF Wirz, BA Stevens, CA Hogan, J Najeeb, ...
Science immunology 5 (54), eabe0240, 2020
4632020
Progenitor identification and SARS-CoV-2 infection in human distal lung organoids
AA Salahudeen, SS Choi, A Rustagi, J Zhu, V van Unen, SM de la O, ...
Nature 588 (7839), 670-675, 2020
3052020
Proinflammatory IgG Fc structures in patients with severe COVID-19
S Chakraborty, J Gonzalez, K Edwards, V Mallajosyula, AS Buzzanco, ...
Nature immunology 22 (1), 67-73, 2021
2542021
Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression
A Piantadosi, D Panteleeff, CA Blish, JM Baeten, W Jaoko, RS McClelland, ...
Journal of virology 83 (19), 10269-10274, 2009
2322009
The innate immune system: fighting on the front lines or fanning the flames of COVID-19?
JL McKechnie, CA Blish
Cell host & microbe 27 (6), 863-869, 2020
2282020
Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
JG Wilson, LJ Simpson, AM Ferreira, A Rustagi, J Roque, A Asuni, ...
JCI insight 5 (17), 2020
2252020
Human B cell clonal expansion and convergent antibody responses to SARS-CoV-2
SCA Nielsen, F Yang, KJL Jackson, RA Hoh, K Röltgen, GH Jean, ...
Cell host & microbe 28 (4), 516-525. e5, 2020
2222020
Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility
DM Strauss-Albee, J Fukuyama, EC Liang, Y Yao, JA Jarrell, AL Drake, ...
Science translational medicine 7 (297), 297ra115-297ra115, 2015
1862015
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ...
Jama 329 (22), 1934-1946, 2023
1822023
Humanized mouse model supports development, function, and tissue residency of human natural killer cells
D Herndler-Brandstetter, L Shan, Y Yao, C Stecher, V Plajer, ...
Proceedings of the National Academy of Sciences 114 (45), E9626-E9634, 2017
1642017
Human natural killer cells mediate adaptive immunity to viral antigens
R Nikzad, LS Angelo, K Aviles-Padilla, DT Le, VK Singh, L Bimler, ...
Science immunology 4 (35), eaat8116, 2019
1582019
Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
AJ Wilk, MJ Lee, B Wei, B Parks, R Pi, GJ Martínez-Colón, T Ranganath, ...
Journal of Experimental Medicine 218 (8), e20210582, 2021
1542021
Zika virus infection induces cranial neural crest cells to produce cytokines at levels detrimental for neurogenesis
NL Bayless, RS Greenberg, T Swigut, J Wysocka, CA Blish
Cell host & microbe 20 (4), 423-428, 2016
1322016
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
P Jagannathan, JR Andrews, H Bonilla, H Hedlin, KB Jacobson, ...
Nature Communications 12 (1), 1967, 2021
1242021
Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses
CA Blish, OC Dogan, NR Derby, MA Nguyen, B Chohan, BA Richardson, ...
Journal of virology 82 (24), 12094-12103, 2008
1182008
The system can't perform the operation now. Try again later.
Articles 1–20